| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |